The Shift in Price Targets
The horizon for Ambipar Participações e Empreendimentos (BOVESPA:AMBP3) just got a bit cloudier. The company’s one-year price target has taken a dip, plunging by 10.63% to 30.01 per share. This revision from the former forecast of 33.58, as of January 16, 2024, has stirred the waters for eager investors.
The new price target is a weighted average derived from multiple forecasts by seasoned analysts. In this blend, the range spans from a low of 21.21 to a high mark of 42.00 per share. The current average target paints a contrasting picture, showcasing a noteworthy surge of 98.21% from the closing price of 15.14 per share.
Tracking Fund Sentiments
A deep dive into the financial sea indicates that a cohort of 130 funds or institutions have been keeping a watchful eye on Ambipar Participações e Empreendimentos. This flock marks an increment of 29 members or a solid 28.71% growth in the last quarter. Remarkably, the average weight of portfolios across all funds dedicated to AMBP3 has scaled down by 15.64%, resting at a modest 0.10%.
When it comes to institutional stakes in the company, there has been a notable swell in the last three months. The total shares under the ownership of these heavy hitters ballooned by 19.08%, reaching a commendable 15,109K shares.
Shifting Shareholder Landscapes
The terrain of Ambipar Participações e Empreendimentos shareholders has witnessed an interesting metamorphosis. The VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, for instance, upped its stake by 59.96%, now holding 1,648K shares, constituting a 0.99% ownership slice of the pie.
Another giant, VGTSX – Vanguard Total International Stock Index Fund Investor Shares, mirrored this trend with a 71.83% boost in shares held. Their current tally stands at 1,617K shares, representing 0.97% ownership of the company. In contrast, PRIDX – T. Rowe Price International Discovery Fund and IEMG – iShares Core MSCI Emerging Markets ETF displayed a static stance, maintaining their positions.
Among the notable movers, GIMFX – GMO Implementation Fund deserves a mention. The fund increased its portfolio allocation by 38.12% over the last quarter, with a 21.68% surge in owned shares reaching 837K.
Fintel stands as a beacon for individual investors, traders, and financial advisors alike, offering a wealth of investing research and data accessible at the click of a button. From ownership insights to fund sentiments and beyond, Fintel equips investors with vital tools to navigate the complex waters of the market.
As investors brace for the winds of change in Ambipar Participações e Empreendimentos, the landscape continues to shift. The fates of individual shares intertwine with broader market trends, ushering in a sense of anticipation and adaptability.
This informative piece first surfaced on Fintel, unveiling the intricate dance of numbers and sentiments that shape the investment realm.
The expressed views in this discussion represent the author’s sentiments and do not necessarily mirror those of Nasdaq, Inc.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
